David G. Jackson
Impact in
- Oncology top 0.02%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Immunology and Allergy top 0.1%
- Cell Adhesion Molecules Research
Papers in
- Oncology 127
- Lymphatic System and Diseases 97
- Cancer Cells and Metastasis 19
-
- Angiogenesis and VEGF in Cancer 42
- Glycosylation and Glycoproteins Research 33
- Co-authors
- Suneale Banerji (24 shared papers)Remko Prevo (13 shared papers)Louise A. Johnson (20 shared papers)Steven Clasper (11 shared papers)Kari Alitalo (9 shared papers)Michael Detmar (6 shared papers)Gavin Screaton (3 shared papers)Claus Cursiefen (8 shared papers)
- Journals
- Journal of Biological Chemistry (20 papers)Differentiation (9 papers)American Journal Of Pathology (9 papers)Journal of Clinical Investigation (8 papers)The Journal of Pathology (8 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David G. Jackson
261 papers receiving 28.3k citations
David G. Jackson's Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 14.5k
- Immunology and Allergy 1.9k
- Cell Biology 4.6k
- Molecular Biology 12.8k
- Cancer Research 2.2k
Countries citing papers authored by David G. Jackson
This map shows the geographic impact of David G. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Jackson more than expected).
Fields of papers citing papers by David G. Jackson
This network shows the impact of papers produced by David G. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Jackson. The network helps show where David G. Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside David G. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 262 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Hit paper breakdown → | 2001 | 1430 |
| 2 | LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan Hit paper breakdown → | 1999 | 1289 |
| 3 | Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Hit paper breakdown → | 2003 | 1073 |
| 4 | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Hit paper breakdown → | 2001 | 996 |
| 5 | Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Hit paper breakdown → | 1992 | 927 |
| 6 | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment Hit paper breakdown → | 2004 | 877 |
| 7 | Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1 Hit paper breakdown → | 2002 | 792 |
| 8 | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 Hit paper breakdown → | 2001 | 614 |
| 9 | Expression of maize KNOTTED1 related homeobox genes in the shoot apical meristem predicts patterns of morphogenesis in the vegetative shoot Hit paper breakdown → | 1994 | 607 |
| 10 | Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages Hit paper breakdown → | 2005 | 574 |
| 11 | Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors Hit paper breakdown → | 2005 | 508 |
| 12 | 2005 | 469 | |
| 13 | 2005 | 450 | |
| 14 | 2004 | 420 | |
| 15 | 2005 | 409 | |
| 16 | 2001 | 401 | |
| 17 | 2003 | 394 | |
| 18 | 2002 | 382 | |
| 19 | 1995 | 364 | |
| 20 | Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. | 2002 | 338 |
About David G. Jackson
David G. Jackson is a scholar working on Oncology, Molecular Biology, Cell Biology, Surgery and Immunology and Allergy, having authored 262 papers that have together received 28.9k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (97 papers), Angiogenesis and VEGF in Cancer (42 papers), Proteoglycans and glycosaminoglycans research (38 papers), Glycosylation and Glycoproteins Research (33 papers), Cell Adhesion Molecules Research (29 papers), Sympathectomy and Hyperhidrosis Treatments (22 papers), Cancer Cells and Metastasis (19 papers) and Vascular Malformations and Hemangiomas (14 papers). The work is most often cited by research in Oncology (14.5k citations), Immunology and Allergy (1.9k citations), Cell Biology (4.6k citations), Molecular Biology (12.8k citations) and Cancer Research (2.2k citations). David G. Jackson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Suneale Banerji, Remko Prevo, Louise A. Johnson, Steven Clasper, Kari Alitalo, Michael Detmar, Gavin Screaton, Claus Cursiefen, J I Bell and Margaret T. Jones. Their work appears in journals such as Journal of Biological Chemistry, Differentiation, American Journal Of Pathology, Journal of Clinical Investigation and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.